Research paperUsing nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine
Section snippets
Background
Ukraine has the highest HIV prevalence in Europe, primarily concentrated in people who inject drugs (PWID) (Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016). Expanding opioid agonist therapies (OAT) with methadone or buprenorphine is the most cost-effective, evidence-based strategy for reducing HIV transmission in Ukraine (Alistar, Owens, & Brandeau, 2011). Buprenorphine was introduced in Ukraine in 2004 (Bruce, Dvoryak, Sylla, & Altice, 2007), followed by methadone in 2008 (Lawrinson
Methods
The current implementation science strategy used in this study is central to the Promoting Action on Research Implementation (PARiHS) framework (Stetler, Damschroder, Helfrich, & Hagedorn, 2011), which focuses on an understanding of the available evidence (i.e., opioid agonist therapies are the most effective treatment for opioid use disorders and very effective HIV prevention strategies), context (i.e., the key ingredient addressed during this NGT activity) and facilitation (i.e., the process
Results
Table 1 presents the entire list of barriers identified by each team and the voting results by team members. Table 2 presents the thematic breakdown and total scores of the top barriers hindering OAT expansion on the regional level in Ukraine. The top barriers for each group were limited to three since the fourth highest ranking barrier had markedly fewer votes than the first three.
The top three barriers to increasing OAT capacity on the regional level identified by the regional change Teams
Discussion
During the NGT process, participants highlighted that the most salient barriers to OAT scale-up in Ukraine are structural factors, such as government policies, that are believed to limit OAT program capacity and flexibility, thereby creating barriers to entry and retention of OAT clients. Specifically, participants stressed the need for reforms at the government level, especially in the Ukrainian MoH, where changes in legislation and policies governing OAT medication procurement and
Conclusions
Scale-up efforts of OAT have been thwarted by many structural barriers on both national and local levels. The use of NGT with OAT stakeholders was an important tool to collaboratively identify and prioritize stakeholder beliefs regarding the multiple complex structural factors that affect OAT expansion in Ukraine. In the context of a learning collaborative focused on improving OAT quality, NGT identified rigid regulatory requirements, inflexible mechanisms for medication distribution, financial
Conflict of interest
None.
References (31)
- et al.
The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment
Journal of Substance Abuse Treatment
(2016) - et al.
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine—programme description and policy implications
International Journal of Drug Policy
(2007) - et al.
Making “stone soup”: Improvements in clinic access and retention in addiction treatment
Joint Commission Journal on Quality and Patient Safety
(2007) - et al.
Evaluation of an advanced physical diagnosis course using consumer preferences methods: The nominal group technique
The American Journal of the Medical Sciences
(2014) - et al.
Replication and sustainability of improved access and retention within the Network for the Improvement of Addiction Treatment
Drug and Alcohol Dependence
(2008) - et al.
Tapping employee insights with the Nominal Group Technique
American Pharmacy
(1990) - et al.
The network for the improvement of addiction treatment (NIATx): Enhancing access and retention
Drug and Alcohol Dependence
(2007) - et al.
Using a NIATx based local learning collaborative for performance improvement
Evaluation and Program Planning
(2011) - et al.
Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine
PLoS Medicine
(2011) - et al.
Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission
Addiction
(2015)
Bureaucracy & beliefs: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine
Drugs: Education, Prevention and Policy
Women with co-occurring disorders (COD): treatment settings and service needs
Journal of Psychoactive Drugs
Facilitating outpatient treatment entry following detoxification for injection drug use: A multisite test of three interventions
Psychology of Addictive Behaviors
Group techniques for program planning—A guide to nominal group and delphi processes
Out of the crisis
Cited by (0)
- 1
Both authors contributed equally to the manuscript as first authors.